Restoring Anti-Oncodriver Th1 Responses with Dendritic Cell Vaccines in HER2/ <i>neu</i> -Positive Breast Cancer: Progress and Potential
2016 · Immunotherapy · 24 citations
https://doi.org/10.2217/imt-2016-0052
L
Lucy M. De La Cruz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
293
Citations
11
h-index
12
i10-index
Lucy M. De La Cruz is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Global Cancer Incidence and Screening & Breast Lesions and Carcinomas. The author has an h-index of 11, co-authored 28 publications.
Papers by this author
worksIs Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged < 50 Years versus ≥ 50 Years, and Trends Over Time
2018 · Annals of Surgical Oncology · 15 citations
https://doi.org/10.1245/s10434-018-6600-9
Practice Changing Potential of TAILORx: A Retrospective Review of the National Cancer Data Base from 2010 to 2015
2019 · Annals of Surgical Oncology · 9 citations
https://doi.org/10.1245/s10434-019-07650-y
Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer
2016 · Annals of Surgical Oncology · 8 citations
https://doi.org/10.1245/s10434-016-5651-z
Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database
2022 · Clinical Breast Cancer · 2 citations
https://doi.org/10.1016/j.clbc.2022.07.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat